Buscador de publicacions

Publicacions

  • Villarroya J, Redondo-Angulo I, Iglesias R, Giralt M, Villarroya F and Planavila A.

    Sirt1 mediates the effects of a short-term high-fat diet on the heart.

    JOURNAL OF NUTRITIONAL BIOCHEMISTRY . 26(11): 1328-1337. Nº de cites: 8

    [doi:10.1016/j.jnutbio.2015.07.029]

  • Gavalda A, Hondares E, Giralt M, Mampel T, Iglesias R and Villarroya F.

    Fibroblast growth factor 21 in breast milk controls neonatal intestine function.

    SCIENTIFIC REPORTS . 5: 13717-13717. Nº de cites: 18

    [doi:10.1038/srep13717]

  • Cereijo R, Villarroya J and Villarroya F.

    Non-sympathetic control of brown adipose tissue.

    International journal of obesity supplements . 5(Suppl 1): .

    [doi:10.1038/ijosup.2015.10]

  • Malandrino MI, Fucho R, Weber M, Calderon-Dominguez M, Mir JF, Valcarcel L, Escoté X, Gómez-Serrano M, Peral B, Salvadó L, Fernández-Veledo S, Casals N, Vazquez M, Villarroya F, Vendrell JJ, Serra D and Herrero L.

    Enhanced fatty acid oxidation in adipocytes and macrophages reduces lipid-induced triglyceride accumulation and inflammation.

    AM J PHYSIOL-ENDOC M . 308(9): . Nº de cites: 89

    [doi:10.1152/ajpendo.00362.2014]

  • Sánchez-Infantes D, Gallego-Escuredo J, Díaz-Silva M, Aragonès G, Sebastiani G, López-Bermejo A, de Zegher F, Domingo P, Villarroya F and Ibañez-Toda L.

    Circulating FGF19 and FGF21 surge in early infancy from infra- to supra-adult concentrations

    INTERNATIONAL JOURNAL OF OBESITY . 39(5): 742-746. Nº de cites: 20

    [doi:10.1038/ijo.2015.2]

  • Planavila A, Redondo-Angulo I, Ribas F, Garrabou G, Casademont J, Giralt M and Villarroya F.

    Fibroblast growth factor 21 protects the heart from oxidative stress.

    CARDIOVASC RES . 106(1): 19-31. Nº de cites: 142

    [doi:10.1093/cvr/cvu263]

  • Cereijo R, Giralt M and Villarroya F.

    Thermogenic brown and beige/brite adipogenesis in humans.

    ANN MED . 47(2): 169-177. Nº de cites: 56

    [doi:10.3109/07853890.2014.952328]

  • Sheedfar F, Vermeer M, Pazienza V, Villarroya J, Rappa F, Cappello F, Mazzoccoli G, Villarroya F, van der Molen H, Hofker MH, Koonen DP and Vinciguerra M.

    Genetic ablation of macrohistone H2A1 leads to increased leanness, glucose tolerance and energy expenditure in mice fed a high-fat diet.

    INTERNATIONAL JOURNAL OF OBESITY . 39(2): 331-338. Nº de cites: 19

    [doi:10.1038/ijo.2014.91]

  • Domingo P, Lamarca MK, Gallego-Escuredo JM, Torres F, Domingo JC, Villarroya J, Gutierrez Mdel M, Mateo MG, Vidal F, Villarroya F and Giralt M.

    Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients.

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 70(6): 1825-1832. Nº de cites: 6

    [doi:10.1093/jac/dkv027]

  • Guzmán-Ruiz R, Ortega F, Rodríguez A, Vázquez-Martínez R, Díaz-Ruiz A, Garcia-Navarro S, Giralt M, Garcia-Rios A, Cobo-Padilla D, Tinahones FJ, López-Miranda J, Villarroya F, Frühbeck G, Fernández-Real JM and Malagón MM.

    Alarmin high-mobility group B1 (HMGB1) is regulated in human adipocytes in insulin resistance and influences insulin secretion in ß-cells.

    INTERNATIONAL JOURNAL OF OBESITY . 38(12): 1545-1554. Nº de cites: 54

    [doi:10.1038/ijo.2014.36]